Gaballa, Mahmoud R.
Ramos, Carlos A.
Article History
First Online: 11 February 2020
Compliance with Ethical Standards
:
: Mahmoud R. Gaballa declares that he has no conflict of interest.Carlos A. Ramos has received compensation from Novartis and Celgene for service on advisory boards and has received research funding from Tessa Therapeutics.
: This article does not contain any studies with human or animal subjects performed by any of the authors.